Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
07:00am, Thursday, 14'th Aug 2025
ST. PAUL, Minn. , Aug. 14, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that the Translational Sciences Labor
CMB.TECH Business update Q2 2025 results
02:33am, Thursday, 14'th Aug 2025
Antwerp, Aug. 14, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its second quarter 2025 earnings prior to market ope
CMB.TECH's update on the Golden Ocean merger process
03:26am, Monday, 11'th Aug 2025
Antwerp, Aug. 11, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) provides an additional market update on the progress of the contemplated stock-for-stock
Bio-Techne (TECH) Q4 EPS Rises 8.2%
06:08pm, Wednesday, 06'th Aug 2025
Bio-Techne (TECH) Q4 EPS Rises 8.2%
Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript
12:52pm, Wednesday, 06'th Aug 2025
Bio-Techne Corporation (NASDAQ:TECH ) Q4 2025 Earnings Conference Call August 6, 2025 9:00 AM ET Company Participants David Clair - VP of Investor Relations & Corporate Development James T. Hippel - E
Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings
10:31am, Wednesday, 06'th Aug 2025
The headline numbers for Techne (TECH) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls
10:05am, Wednesday, 06'th Aug 2025
TECH tops Q4 EPS estimates and posts solid revenues, but shrinking margins and operating loss drag shares lower.
Techne (TECH) Beats Q4 Earnings and Revenue Estimates
08:51am, Wednesday, 06'th Aug 2025
Techne (TECH) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.49 per share a year ago.
Bio-Techne beats quarterly estimates on strength in protein sciences unit
08:08am, Wednesday, 06'th Aug 2025
Bio-Techne reported better-than-expected fourth-quarter revenue and profit on Wednesday, helped by steady demand for its proteins, antibodies and other products for research.
Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
06:30am, Wednesday, 06'th Aug 2025
MINNEAPOLIS , Aug. 6, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2025. Fourth Quarter FY2025 Highlights Four
BIO-TECHNE DECLARES DIVIDEND
06:30am, Wednesday, 06'th Aug 2025
MINNEAPOLIS , Aug. 6, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30,
Bio-Techne Announces Exosome Diagnostics Divestiture
04:30pm, Tuesday, 05'th Aug 2025
MINNEAPOLIS , Aug. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoD
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
07:00am, Tuesday, 05'th Aug 2025
ST. PAUL, Minn. , Aug. 5, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and child
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
10:56am, Monday, 04'th Aug 2025
TECH eyes modest Q4 growth as strong reagent and instrumentation demand offsets NIH and tariff concerns.
ST. PAUL, Minn. , July 31, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that three investigato
